{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-017680","form_type":"8-K","ticker":"CHRN","cik":"0001549084","company_name":"EKSO BIONICS HOLDINGS, INC.","filed_at":"2025-05-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.720349+00:00","generated_at":"2026-05-20T23:57:38.817632+00:00","sec_items":["5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Ekso Bionics approves 1-for-15 reverse stock split effective May 27, 2025 to regain Nasdaq compliance","bullets":["Reverse split ratio set at 1-for-15; effective 12:01 a.m. PT on May 27, 2025.","Post-split shares ~2.35M vs pre-split ~35.3M; par value unchanged at $0.001.","Stock will trade on Nasdaq (symbol EKSO) on split-adjusted basis; new CUSIP 282644400.","Fractional shares rounded up to next whole share; no proportional cut in authorized shares.","Purpose: raise per-share price to meet $1 minimum bid for 10 consecutive trading days."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-017680","json":"https://secwatch.observer/filing/0001437749-25-017680.json","markdown":"https://secwatch.observer/filing/0001437749-25-017680.md","text":"https://secwatch.observer/filing/0001437749-25-017680.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1549084/000143774925017680/0001437749-25-017680-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1549084/000143774925017680/ekso20250516c_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T23:57:38.817632+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}